ALDH2 genotype modulates the association between alcohol consumption and AST/ALT ratio among middle-aged Japanese men: a genome-wide G × E interaction analysis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 24 03 2020
accepted: 11 09 2020
entrez: 2 10 2020
pubmed: 3 10 2020
medline: 13 1 2021
Statut: epublish

Résumé

Liver tests (LT), especially to measure AST, ALT and GGT levels, are widely used to evaluate the risk of alcohol-related liver disease (ALD). In this study, we investigated the potential genetic factors that modulate the association between LTs and alcohol consumption. We conducted a genome-wide interaction meta-analysis in 7856 Japanese subjects from Tohoku Medical Megabank Community-Based Cohort (TMM CommCohort) study recruited in 2013, and identified 2 loci (12q24 and 2p16) with genome-wide significance (P > 5 × 10

Identifiants

pubmed: 33004991
doi: 10.1038/s41598-020-73263-1
pii: 10.1038/s41598-020-73263-1
pmc: PMC7530747
doi:

Substances chimiques

ALDH2 protein, human EC 1.2.1.3
Aldehyde Dehydrogenase, Mitochondrial EC 1.2.1.3
Aspartate Aminotransferases EC 2.6.1.1
Alanine Transaminase EC 2.6.1.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16227

Références

Connor, J. P., Haber, P. S. & Hall, W. D. Alcohol use disorders. Lancet 387, 988–998 (2016).
pubmed: 26343838
Rehm, J., Samokhvalov, A. V. & Shield, K. D. Global burden of alcoholic liver diseases. J. Hepatol. 59, 160–168 (2013).
pubmed: 23511777
Galle, P. R. et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol. 69, 182–236 (2018).
European Association for the Study of the Liver. Corrigendum to ‘EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma’ [J Hepatol 69 (2018) 182–236]. J. Hepatol. 70, 817 (2019).
O’Shea, R. S., Dasarathy, S. & McCullough, A. J. Practice Guideline Committee of the American Association for the Study of Liver Diseases & Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology 51, 307–328 (2010).
pubmed: 20034030
Bataller, R. & Gao, B. Liver fibrosis in alcoholic liver disease. Semin. Liver Dis. 35, 146–156 (2015).
pubmed: 25974900
Nyblom, H. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol. 39, 336–339 (2004).
pubmed: 15208167
Cohen, J. A. & Kaplan, M. M. The SGOT/SGPT ratio—An indicator of alcoholic liver disease. Dig. Dis. Sci. 24, 835–838 (1979).
pubmed: 520102
Malakouti, M., Kataria, A., Ali, S. K. & Schenker, S. Elevated liver enzymes in asymptomatic patients—What should I do?. J. Clin. Transl. Hepatol. 5, 394–403 (2017).
pubmed: 29226106 pmcid: 5719197
Scouller, K., Conigrave, K. M., Macaskill, P., Irwig, L. & Whitfield, J. B. Should we use carbohydrate-deficient transferrin instead of gamma-glutamyltransferase for detecting problem drinkers? A systematic review and metaanalysis. Clin. Chem. 46, 1894–1902 (2000).
pubmed: 11106319
Conigrave, K. M., Davies, P., Haber, P. & Whitfield, J. B. Traditional markers of excessive alcohol use. Addiction 98(Suppl 2), 31–43 (2003).
pubmed: 14984240
Kim, S. M. et al. Carbohydrate-deficient transferrin as a marker of heavy drinking in Korean males. J. Korean Med. Sci. 22, 652–655 (2007).
pubmed: 17728504 pmcid: 2693814
Conigrave, K. M. et al. CDT, GGT, and AST as markers of alcohol use: The WHO/ISBRA collaborative project. Alcohol. Clin. Exp. Res. 26, 332–339 (2002).
pubmed: 11923585
Chambers, J. C. et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat. Genet. 43, 1131–1138 (2011).
pubmed: 22001757 pmcid: 3482372
Rahmioglu, N. et al. Epidemiology and genetic epidemiology of the liver function test proteins. PLoS ONE 4, e4435 (2009).
pubmed: 19209234 pmcid: 2636884
Whitfield, J. B., Zhu, G., Nestler, J. E., Heath, A. C. & Martin, N. G. Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors. Clin. Chem. 48, 1426–1431 (2002).
pubmed: 12194918
Stickel, F., Moreno, C., Hampe, J. & Morgan, M. Y. The genetics of alcohol dependence and alcohol-related liver disease. J. Hepatol. 66, 195–211 (2017).
pubmed: 27575312
Matoba, N. et al. GWAS of 165,084 Japanese individuals identified nine loci associated with dietary habits. Nat. Hum. Behav. 4, 308–316 (2020).
pubmed: 31959922
Kanai, M. et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat. Genet. 50, 390–400 (2018).
pubmed: 29403010
Kraft, P., Yen, Y.-C., Stram, D. O., Morrison, J. & Gauderman, W. J. Exploiting gene-environment interaction to detect genetic associations. HHE 63, 111–119 (2007).
Hachiya, T. et al. Genome-wide analysis of polymorphism × sodium interaction effect on blood pressure identifies a novel 3’-BCL11B gene desert locus. Sci. Rep. 8, 14162 (2018).
pubmed: 30242241 pmcid: 6155053
Kuriyama, S. et al. The Tohoku Medical Megabank Project: Design and mission. J. Epidemiol. 26, 493–511 (2016).
pubmed: 27374138
Japan Society of Clinical Chemistry. A review of the consensus method for measure of enzymatic activity in human serum [in Japanese]. Jpn. J. Clin. Chem. 18, 211–262 (1989).
Iso, H. et al. Alcohol consumption and risk of stroke among middle-aged men: The JPHC Study Cohort I. Stroke 35, 1124–1129 (2004).
pubmed: 15017008
Kerr, W. C. & Stockwell, T. Understanding standard drinks and drinking guidelines. Drug Alcohol Rev. 31, 200–205 (2012).
pubmed: 22050262
Hachiya, T. et al. Genome-wide meta-analysis in Japanese populations identifies novel variants at the TMC6-TMC8 and SIX3-SIX2 loci associated with HbA1c. Sci. Rep. 7, 16147 (2017).
pubmed: 29170429 pmcid: 5701039
Hachiya, T. et al. Genetic predisposition to ischemic stroke: A polygenic risk score. Stroke 48, 253–258 (2017).
pubmed: 28034966 pmcid: 5266416
Delaneau, O., Marchini, J. & Zagury, J.-F. A linear complexity phasing method for thousands of genomes. Nat. Methods 9, 179–181 (2011).
pubmed: 22138821
Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284–1287 (2016).
pubmed: 27571263 pmcid: 5157836
Auton, A. et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: Fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
pubmed: 20616382 pmcid: 20616382
Minegishi, N. et al. Biobank establishment and sample management in the Tohoku Medical Megabank Project. Tohoku J. Exp. Med. 248, 45–55 (2019).
pubmed: 31130587
Yasuda, J. et al. Genome analyses for the Tohoku Medical Megabank Project towards establishment of personalized healthcare. J. Biochem. 165, 139–158 (2019).
pubmed: 30452759
Tadaka, S. et al. 3.5KJPNv2: An allele frequency panel of 3552 Japanese individuals including the X chromosome. Hum. Genome Var. 6, 28 (2019).
pubmed: 31240104 pmcid: 6581902
Nagasaki, M. et al. Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals. Nat. Commun. 6, 8018 (2015).
pubmed: 26292667 pmcid: 4560751
Kawai, Y. et al. Japonica array: Improved genotype imputation by designing a population-specific SNP array with 1070 Japanese individuals. J. Hum. Genet. 60, 581–587 (2015).
pubmed: 26108142 pmcid: 4635170
Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
pubmed: 25642630 pmcid: 25642630
Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).
pubmed: 26414676 pmcid: 4797329
Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997–1004 (1999).
pubmed: 11315092
Crabb, D. W., Edenberg, H. J., Bosron, W. F. & Li, T. K. Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant. J. Clin. Investig. 83, 314–316 (1989).
pubmed: 2562960
Aschard, H., Vilhjálmsson, B. J., Joshi, A. D., Price, A. L. & Kraft, P. Adjusting for heritable covariates can bias effect estimates in genome-wide association studies. Am. J. Hum. Genet. 96, 329–339 (2015).
pubmed: 25640676 pmcid: 4320269
Keller, M. C. Gene × environment interaction studies have not properly controlled for potential confounders: The problem and the (simple) solution. Biol. Psychiatry 75, 18–24 (2014).
pubmed: 24135711
Lee, J. K. et al. Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology. Hepatology 51, 1577–1583 (2010).
pubmed: 20162730
Prati, D. et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann. Intern. Med. 137, 1–10 (2002).
pubmed: 12093239
Botros, M. & Sikaris, K. A. The de ritis ratio: The test of time. Clin. Biochem. Rev. 34, 117–130 (2013).
pubmed: 24353357 pmcid: 3866949
Singal, A. K., Bataller, R., Ahn, J., Kamath, P. S. & Shah, V. H. ACG clinical guideline: Alcoholic liver disease. Am. J. Gastroenterol. 113, 175–194 (2018).
pubmed: 29336434 pmcid: 6524956
Wolff, P. H. Ethnic differences in alcohol sensitivity. Science 175, 449–450 (1972).
pubmed: 5007912
Harada, S., Agarwal, D. P. & Goedde, H. W. Aldehyde dehydrogenase deficiency as cause of facial flushing reaction to alcohol in Japanese. Lancet 2, 982 (1981).
pubmed: 6117742
Li, Y. et al. Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. J. Clin. Investig. 116, 506–511 (2006).
pubmed: 16440063
Xiao, Q., Weiner, H., Johnston, T. & Crabb, D. W. The aldehyde dehydrogenase ALDH2*2 allele exhibits dominance over ALDH2*1 in transduced HeLa cells. J. Clin. Investig. 96, 2180–2186 (1995).
pubmed: 7593603
Nose, J., Saito, A. & Kamatani, N. Statistical analysis of the associations between polymorphisms within aldehyde dehydrogenase 2 (ALDH2), and quantitative and qualitative traits extracted from a large-scale database of Japanese single-nucleotide polymorphisms (SNPs). J. Hum. Genet. 53, 425–438 (2008).
pubmed: 18317873
Takeuchi, F. et al. Confirmation of ALDH2 as a major locus of drinking behavior and of its variants regulating multiple metabolic phenotypes in a Japanese population. Circ. J. 75, 911–918 (2011).
pubmed: 21372407
Kamatani, Y. et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat. Genet. 42, 210–215 (2010).
pubmed: 20139978
Li, D., Zhao, H. & Gelernter, J. Strong protective effect of the aldehyde dehydrogenase gene (ALDH2) 504lys (*2) allele against alcoholism and alcohol-induced medical diseases in Asians. Hum. Genet. 131, 725–737 (2012).
pubmed: 22102315
Hoshi, H. et al. Aldehyde-stress resulting from Aldh2 mutation promotes osteoporosis due to impaired osteoblastogenesis. J. Bone Miner. Res. 27, 2015–2023 (2012).
pubmed: 22508505
Shimizu, Y. et al. Reduced bone formation in alcohol-induced osteopenia is associated with elevated p21 expression in bone marrow cells in aldehyde dehydrogenase 2-disrupted mice. Bone 48, 1075–1086 (2011).
pubmed: 21256255
Matsuda, T. et al. Increased formation of hepatic N2-ethylidene-2’-deoxyguanosine DNA adducts in aldehyde dehydrogenase 2-knockout mice treated with ethanol. Carcinogenesis 28, 2363–2366 (2007).
pubmed: 17361010
Matsuo, K. Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis 22, 913–916 (2001).
pubmed: 11375898
Matsuo, K. et al. Aldehyde dehydrogenase 2 (ALDH2) genotype affects rectal cancer susceptibility due to alcohol consumption. J. Epidemiol. 12, 70–76 (2002).
pubmed: 12033531
Ueland, P. M., Ulvik, A., Rios-Avila, L., Midttun, Ø & Gregory, J. F. Direct and functional biomarkers of vitamin B6 status. Annu. Rev. Nutr. 35, 33–70 (2015).
pubmed: 25974692 pmcid: 5988249
Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005–D1012 (2019).
pubmed: 30445434
Li, Q., Lu, J., Xia, J., Wen, M. & Wang, C. Long non-coding RNA LOC730100 enhances proliferation and invasion of glioma cells through competitively sponging miR-760 from FOXA1 mRNA. Biochem. Biophys. Res. Commun. 512, 558–563 (2019).
pubmed: 30914197
Lee, C. S., Friedman, J. R., Fulmer, J. T. & Kaestner, K. H. The initiation of liver development is dependent on Foxa transcription factors. Nature 435, 944–947 (2005).
pubmed: 15959514
Pruim, R. J. et al. LocusZoom: Regional visualization of genome-wide association scan results. Bioinformatics 26, 2336–2337 (2010).
pubmed: 20634204 pmcid: 20634204

Auteurs

Yoichi Sutoh (Y)

Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 1-1-1 Idaidori, Yahaba, Iwate, 028-3694, Japan.

Tsuyoshi Hachiya (T)

Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 1-1-1 Idaidori, Yahaba, Iwate, 028-3694, Japan.

Yuji Suzuki (Y)

Division of Hepatology, Department of Internal Medicine, Iwate Medical University, Yahaba, Japan.

Shohei Komaki (S)

Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 1-1-1 Idaidori, Yahaba, Iwate, 028-3694, Japan.

Hideki Ohmomo (H)

Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 1-1-1 Idaidori, Yahaba, Iwate, 028-3694, Japan.

Keisuke Kakisaka (K)

Division of Hepatology, Department of Internal Medicine, Iwate Medical University, Yahaba, Japan.

Ting Wang (T)

Division of Biomedical Research and Development, Institute of Biomedical Sciences, Iwate Medical University, Morioka, Iwate, Japan.

Yasuhiro Takikawa (Y)

Division of Hepatology, Department of Internal Medicine, Iwate Medical University, Yahaba, Japan.

Atsushi Shimizu (A)

Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 1-1-1 Idaidori, Yahaba, Iwate, 028-3694, Japan. ashimizu@iwate-med.ac.jp.
Division of Biomedical Information Analysis, Institute for Biomedical Sciences, Iwate Medical University, 1-1-1 Idaidori, Yahaba, Iwate, 028-3694, Japan. ashimizu@iwate-med.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH